Abstract
Hpertension is an important health problem throughout the world and a risk factor for many diseases. Angiotensin-converting enzyme (ACE), a component of the renin-angiotensin system, has an important role in the regulation of blood pressure. Zinc (Zn), a trace element with important biological functions, is located in the catalytic site of ACE. Calcium (Ca), magnesium (Mg), sodium (Na), and potassium (K) also appear to be involved in hypertension pathogenesis. In this study, plasma ACE activities and Cat, Cai, Mg, Na, K, and plasma/erythrocyte Zn levels of 20 untreated patients with essential hypertension and 28 helthy individuals were evaluated. Plasma ACE activities (p<0.05) and erythrocyte Zn concentrations (p<0.001) were significantly higher in patients with essential hypertension than values of the control group. No significant difference was found between plasma Zn concentrations of the groups (p>0.05). Plasma Cat (p<0.001) and Mg levels (p<0.05) in essential hypertension were significantly lower than those of controls. Plasma Na, K, and Cai levels remained normal in essential hypertension. There are complex associations between metals and arterial pressure. Ca and Mg deficiencies seem to be associated with increased prevalence of hypertension. Increases in erythrocyte Zn may have a future potential use for diagnosis of hypertension.
Similar content being viewed by others
References
S. A. Fauci, E. Braunwald, and K. J. Isselbacher, Harrison’s Principles of Internal Medicine, 14th ed., New York (1998).
J. R. Edward, R. W. Giffard, and M. D. Alderman, The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNCV), Arch. Intern. Med. 153, 154–183 (1993).
R. Berkow, Hypertension, etiology and pathogenesis, in The Merck Manual (1988).
J. Wyngaurde, Arterial hypertension, in Cecil Textbook of Medicine (1988).
E. Zbroch, J. Malyszko, and N. Mysliwiec, New concept in pathogenesis of essential hypertension, Przegl. Lek. 56(4), 281–285 (1999).
K. Allikmets, T. Parik, and N. Vigimau, The renin-angiotensin system in essential hypertension: associations with cardiovascular risk, Blood Press. 8(2), 70–78 (1999).
G. M. Reaven, H. Lithell, and L. Landsberg, Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system, N. Engl. J. Med. 8, 374–380 (1996).
A. Harjanne, Automated kinetic determination of ACE in serum, Clin. Chem. 30, 901–902 (1984).
D. B. Milne, Trace elements, In Tietz Textbook of Clinical Chemistry, 3rd.ed., Burtis and Ashwood, eds., W. B. Saunders, Philadelphia, pp. 1029–1055 (1999).
J. B. Cali, A reference method for the determinant of calcium in serum. N.B.S. 260, 32 (1972).
Celleenananalyzer Ca 460 Kataloğu.
Ciba Corning Na — K Analyzer Kataloğu. Cat No : 478639.
Z. Hlubocka, V. Umnerova, S. Heller, et al., Circulating intercellular cell adhesion molecule-1 endothelin-1 and Von Willebrandt factor—markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J. Hum. Hypertens. 16(8), 557–562 (2002).
W. Kosmala, Endothelial dysfunction in hypertension—clinical implications, Pol. Merkuriusz Lek. 2(70), 333–335 (2002).
B. Baudin, New aspects on angiotensin-converting enzyme: from gene to disease, Clin. Chem. Lab. Med. 40(3), 256–265 (2002).
A. J. Turner, and N. M. Hooper, The angiotensin-converting enzyme gene family: genomics and pharmacology, Trends Pharmacol. Sci. 23(4), 177–183 (2002).
P. Corvol, A. Michaud, F. Soubrier, and T. A. Williams, Recent advances in knowledge of the structure and function of the angiotensin-converting enzyme, J. Hypertens. 13(Suppl. 3), 3–10 (1995).
A. Bedir, N. Arik, B. Adam, K. Kilinc, T. Gumus, and E. Guner, Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension, Am. J. Hypertens. 2(10 Pt. 1), 1038–1043 (1999).
T. Tamura, G. L. Johanning, R. L. Goldenberg, R. L. Johnston, K. E. Johnston, and M. B. DuBard, Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration, Obstet. Gynecol. 88(4 Pt. 1), 497–502 (1996).
G. Vivoli, M. Bergomi, S. Rovesti, M. Pinotti, and E. Caselgrandi, Zinc, copper, and zinc- or copper-dependent enzymes in human hypertension, Biol. Trace Element Res. 49(2–3), 97–106 (1995).
G. Uza, O. Pavel, A. Kovacs, D. Uza, and R. Vlaicu, Serum concentration of Na, K, Ca, Mg, P, Zn and Cu in patients with essential arterial hypertension, Clin. Exp. Hypertens. (A) 6(8), 1415–1429 (1984).
C. Russo, O. Olivieri, D. Girelli, and G. Faccini, Anti-oxidant status and lipid peroxidation in patients with essential hypertension, J. Hypertens. 16(9), 1267–1271 (1998).
S. Ripa, and R. Ripa, Zinc and arterial pressure, Minerva Med. 85(9), 455–459 (1994).
P. Pras, J. M. Bayada, F. Bertrand, et al., The effect of various diseases on the zinc plasma level, Semin. Hop. 59(20), 1519–1522 (1983).
A. Haenni, A. Fugmann, L. Lind, and H. Lithell, Systolic blood pressure alterations during hyperinsulinemia are related to changes in ionized calcium status, Am. J. Hypertens. 14 (11 Pt. 1), 1106–1111 (2001).
M. Barbagallo, R. K. Gupta, L. J. Dominquez, and L. M. Resnick, Cellular ionic alterations with age: relation to hypertension and diabetes, J. Am Geriatr. Soc. 48(9), 1111–1116 (2000).
J. L. Garcia Zozaya and M. Padilla Viloria, Alterations of calcium, magnessium, and zinc in essential hypertension: their relation to the renin-angiotensin-aldesterone system, Invest. Clin. 38(Suppl. 2), 27–40 (1997).
Y. Fu, S. Wang, Z. Lu, H. Li, and S. Li, Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension, Chin. Med. J. (Engl.) 111(2), 147–149 (1998).
K. Sudhakar, M. Sujatha, V. B. Rao, A. Jyothy, and P. P. Reddy, Serum and erythrocyte magnesium levels in hypertensives and their first degree relatives, J. Indian Med. Assoc. 97(6), 211–213 (1999).
J. A. McKnight, G. Roberts, B. Sheridan, and A. B. Atkinson, The effect of low and high sodium diets on plasma atrial natriuretic factor, the renin-aldosterone system and blood pressure in subjects with essential hypertension, Clin. Endocrinol. (Oxf). 40(1), 73–77 (1994).
L. Gesang, G. Liu, W. Cen, et al., Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibeten population, Hypertens. Res. 25(3), 481–485 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ekmekci, O.B., Donma, O. & Tunckale, A. Angiotensin-converting enzyme and metals in untreated essential hypertension. Biol Trace Elem Res 95, 203–210 (2003). https://doi.org/10.1385/BTER:95:3:203
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:95:3:203